Tirzepatide is a dual GLP-1/GIP receptor agonist that has shown up to 20-22% average body weight loss in clinical trials — the most effective weight loss medication currently available. Marketed as Mounjaro (diabetes) and Zepbound (weight loss), we prescribe and manage this medication with careful dose titration and monitoring.
Signs & symptoms
- BMI ≥ 30 (obesity)
- BMI ≥ 27 with weight-related condition
- Previous experience with semaglutide (seeking stronger results)
- Metabolic syndrome or insulin resistance
- Weight-related health conditions not improving with lifestyle changes
- Interest in the most effective medication-assisted option available
Our approach
Tirzepatide is titrated from 2.5mg weekly, increasing every 4 weeks based on tolerability. Side effects are similar to semaglutide (GI-related) and typically improve. We track weight, labs, and side effects at each visit. Like all GLP-1 medications, this works best with dietary and activity modifications.
Who is this for?
Adults meeting BMI criteria who want the most potent medication-assisted weight loss option, including those who may have plateaued on semaglutide.
Start your journey to total wellness today.
No referral needed. Most major insurance plans accepted. Telehealth appointments available across DC and Maryland.